These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28865942)

  • 1. Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation.
    Fayos-Vidal F; Arzamendi-Aizpurua D; Millán-Álvarez X; Guisado-Alonso D; Camps-Renom P; Prats-Sánchez L; Martínez-Domeño A; Delgado-Mederos R; Martí-Fàbregas J
    Neurologia (Engl Ed); 2020; 35(1):10-15. PubMed ID: 28865942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
    Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
    Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
    Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism.
    Pouru JP; Lund J; Jaakkola S; Vasankari T; Biancari F; Saraste A; Airaksinen KEJ
    Heart Rhythm; 2020 Jun; 17(6):915-921. PubMed ID: 32036026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Appendage Closure in Patients With Intracranial Hemorrhage and Nonvalvular Atrial Fibrillation.
    Ajmal M; Naik H; Kocheril A
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104685. PubMed ID: 32057654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage.
    Hutt E; Wazni OM; Saliba WI; Kanj M; Tarakji KG; Aguilera J; Barakat AF; Rasmussen P; Uchino K; Russman A; Hussain S; Wisco D; Kapadia S; Lindsay BD; Hussein AA
    Heart Rhythm; 2019 May; 16(5):663-668. PubMed ID: 30521942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.
    Urena M; Rodés-Cabau J; Freixa X; Saw J; Webb JG; Freeman M; Horlick E; Osten M; Chan A; Marquis JF; Champagne J; Ibrahim R
    J Am Coll Cardiol; 2013 Jul; 62(2):96-102. PubMed ID: 23665098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage.
    Fahmy P; Spencer R; Tsang M; Gooderham P; Saw J
    Can J Cardiol; 2016 Mar; 32(3):349-54. PubMed ID: 26831513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation.
    Saw J; Bennell MC; Singh SM; Wijeysundera HC
    Can J Cardiol; 2016 Nov; 32(11):1355.e9-1355.e14. PubMed ID: 27432692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.